| Year |
Citation |
Score |
| 2023 |
Magbanua MJM, van 't Veer L, Clark AS, Chien AJ, Boughey JC, Han HS, Wallace A, Beckwith H, Liu MC, Yau C, Wileyto EP, Ordonez A, Solanki TI, Hsiao F, Lee JC, ... ... Bayne L, et al. Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study. Breast Cancer Research and Treatment. PMID 36689092 DOI: 10.1007/s10549-022-06803-0 |
0.574 |
|
| 2018 |
Bayne L, Nivar I, Goodspeed B, Wileyto P, Savage J, Shih N, Feldman, Edwards J, Clark A, Fox K, Matro J, Domchek S, Bradbury A, Shah P, Chislock E, et al. Abstract OT2-07-09: Detection and targeting of minimal residual disease in breast cancer to reduce recurrence: The PENN-SURMOUNT and CLEVER trials Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Ot2-07-09 |
0.387 |
|
| 2015 |
Lee KE, Spata M, Bayne LJ, Buza EL, Durham AC, Allman D, Vonderheide RH, Simon MC. Hif1α deletion reveals pro-neoplastic function of B cells in pancreatic neoplasia. Cancer Discovery. PMID 26715642 DOI: 10.1158/2159-8290.Cd-15-0822 |
0.614 |
|
| 2013 |
Bayne LJ, Vonderheide RH. Multicolor flow cytometric analysis of immune cell subsets in tumor-bearing mice. Cold Spring Harbor Protocols. 2013: 955-60. PMID 24086051 DOI: 10.1101/Pdb.Prot077198 |
0.614 |
|
| 2013 |
Bayne LJ, Vonderheide RH. Methods for analysis of the immune system in mouse cancer models. Cold Spring Harbor Protocols. 2013: 901-3. PMID 24086048 DOI: 10.1101/Pdb.Top069971 |
0.659 |
|
| 2013 |
Bayne LJ, Vonderheide RH. A myeloid-derived suppressor cell-mediated T-cell suppression assay for functional evaluation of immune cells in tumor-bearing mice. Cold Spring Harbor Protocols. 2013: 849-53. PMID 24003206 DOI: 10.1101/Pdb.Prot077214 |
0.624 |
|
| 2013 |
Bayne LJ, Vonderheide RH. Immunohistochemical assessment of immune cells in mouse tumor tissue. Cold Spring Harbor Protocols. 2013: 843-8. PMID 24003205 DOI: 10.1101/Pdb.Prot077206 |
0.554 |
|
| 2013 |
Vonderheide RH, Bajor DL, Winograd R, Evans RA, Bayne LJ, Beatty GL. CD40 immunotherapy for pancreatic cancer. Cancer Immunology, Immunotherapy : Cii. 62: 949-54. PMID 23589109 DOI: 10.1007/S00262-013-1427-5 |
0.676 |
|
| 2013 |
Vonderheide RH, Bayne LJ. Inflammatory networks and immune surveillance of pancreatic carcinoma. Current Opinion in Immunology. 25: 200-5. PMID 23422836 DOI: 10.1016/J.Coi.2013.01.006 |
0.7 |
|
| 2012 |
Bayne LJ, Beatty GL, Jhala N, Clark CE, Rhim AD, Stanger BZ, Vonderheide RH. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell. 21: 822-35. PMID 22698406 DOI: 10.1016/J.Ccr.2012.04.025 |
0.714 |
|
| 2011 |
Stairs DB, Bayne LJ, Rhoades B, Vega ME, Waldron TJ, Kalabis J, Klein-Szanto A, Lee JS, Katz JP, Diehl JA, Reynolds AB, Vonderheide RH, Rustgi AK. Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. Cancer Cell. 19: 470-83. PMID 21481789 DOI: 10.1016/J.Ccr.2011.02.007 |
0.685 |
|
| 2011 |
Stairs DB, Bayne LJ, Rhoades B, Vega ME, Nakagawa H, Klein-Szanto AJ, Katz JP, Reynolds AB, Vonderheide RH, Rustgi AK. Loss of P120-Catenin Results in Esophageal Tumorigenesis, Involving the Recruitment of Immature Myeloid Cells to the Tumor Microenvironment Gastroenterology. 140: S-182. DOI: 10.1016/S0016-5085(11)60735-X |
0.643 |
|
| 2010 |
Stairs D, Bayne LJ, Rhoades B, Mui KL, Kalabis J, Nakagawa H, Wong GS, Grugan KD, Klein-Szanto AJ, Lee J, Katz JP, Vonderheide RH, Reynolds AB, Rustgi AK. 847g Inactivation of the P120-Catenin Gene Results in a Tumor Microenvironment With Inflammation and Cancer That Establishes Its Identity as a Bone Fide Tumor Suppressor Gastroenterology. 138: S-112. DOI: 10.1016/S0016-5085(10)60513-6 |
0.627 |
|
| Show low-probability matches. |